Legal Representation
Attorney
Matthew P. Hintz, Esq.
USPTO Deadlines
Next Deadline
55 days remaining
Non-Final Action E-Mailed
Due Date
February 18, 2026
Extension Available
Until May 18, 2026
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 18, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 17, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 17, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 17, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 18, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 18, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 18, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 18, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 30, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 30, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 30, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development in the field of pharmaceuticals and biopharmaceuticals; Product development in the field of pharmaceutical and biopharmaceutical preparations, inserts being implantable intravitreal drug delivery devices, implants, and medicines; Development of pharmaceutical preparations and medicines; Product development in the field of pharmaceuticals and biopharmaceuticals
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
RETINA